And it's through the lens of these experiences that I urge our industry to accelerate progress in safety, as we relentlessly pursue zero harm. Beyond the MD label, I am, of course, a human first. A ...
Overall, RoundRight has signed contracts with 13 behavioral health care facilities in Pennsylvania, North Dakota and Arkansas ...
Palvella Therapeutics announced the first patient has been dosed in SELVA, a multicenter, Phase 3 clinical trial designed to evaluate the ...
Houston-based MD Anderson Cancer Center's hemovigilance unit was born from a blood transfusion-related event that led to a patient's death in 2019. Kimberly Klein, MD, medical director of the unit, ...
Gilead and Arcellx’s early trial data on their multiple myeloma cell therapy show that patients saw no cases of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback